0|10000|Public
40|$|Source of support: Departmental sources Background: In {{patients}} presenting with non-ST elevation <b>myocardial</b> <b>infarction,</b> {{we investigated}} {{the relationship of}} left atri-al deformational parameters evaluated by 2 -dimensional speckle tracking imaging (2 D-STI) with conventional echocardiographic diastolic dysfunction parameters and brain natriuretic peptide level. Material/Methods: We enrolled 74 <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> patients who were treated with percutaneous coronary intervention and 58 healthy control subjects. <b>Non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> pa-tients had echocardiographic examination 48 h after the percutaneous coronary intervention procedure and venous blood samples were drawn simultaneously. In addition to conventional echocardiographic parameters, left atrial strain curves were obtained for each patient. Average peak left atrial strain values during left ventric-ular systole were measured. Results: BNP values were higher in <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> patients compared to controls. Mean left atrium peak systolic global longitudinal strain in Group 2 (the control group) was {{higher than in the}} <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> group. Left atrium peak systolic global longitudinal strain was sig-nificantly correlated with left ventricular ejection fraction. There was a significant inverse correlation between left atrium peak systolic global longitudinal strain and brain natriuretic peptide level, left atrium volume max...|$|R
40|$|Background: Myocardial {{fractional}} flow reserve (FFR) has uncertain validity {{in patients}} with recent <b>myocardial</b> <b>infarction</b> {{and the use of}} FFR in this setting is controversial. We performed a prospective study to assess the diagnostic accuracy of FFR {{in patients with}} a recent <b>non-ST</b> <b>segment</b> <b>myocardial</b> <b>infarction</b> (NSTEMI). Methods: NSTEMI patients who had been referred for early invasive management were included. FFR was measured in all major patent epicardial coronary arteries with a visual stenosis estimated at ≥ 30...|$|R
40|$|PURPOSE OF THE STUDY: To examine {{differences}} in the characteristics, treatment practices and in-hospital outcomes of patients with and without previously diagnosed diabetes hospitalized for <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction.</b> KEY METHODS: The study cohort consisted of 3916 patients diagnosed with <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> at all 11 central MA medical centres between 1999 and 2009, of whom 1475 (38 %) had been previously diagnosed with diabetes. MAIN RESULTS: Diabetic patients {{were more likely to}} have received treatment with effective cardiac medications, and to have undergone coronary bypass surgery, but were less likely to have received a percutaneous coronary intervention, than non-diabetic patients. Patients with a history of diabetes {{were more likely to have}} developed cardiogenic shock, heart failure and died during their index hospitalization than non-diabetic patients. MAIN CONCLUSION: Diabetic patients presenting with <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> remain at high risk of developing significant clinical complications during hospitalization...|$|R
2500|$|These {{types are}} named {{according}} to {{the appearance of the}} electrocardiogram (ECG/EKG) as <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> and ST <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> [...] There can be some variation as to which forms of <b>myocardial</b> <b>infarction</b> (MI) are classified under acute coronary syndrome.|$|R
40|$|Advanced lower {{extremity}} peripheral artery disease (PAD) represents a relatively uncommon, but excep-tionally high-risk, manifestation of systemic atheroscler-osis. Both traditional PAD classification systems and recent evidence-based PAD care guidelines have em-phasized the potential benefit of more consistent case classification of advanced PAD into two distinct clinical syndromes, denoted as acute limb ischemia (ALI) or chronic critical limb ischemia (CLI). Both PAD syn-dromes represent manifestations of a severe comprom-ise of arterial {{blood flow to}} the affected {{lower extremity}}, with the acuity of onset of ischemia and specific clinical signs used to distinguish between these syndromes [1]. In contrast to comparable acute coronary disease syn-dromes (such as the acute coronary syndromes [ACS] of <b>non-ST</b> <b>segment</b> <b>myocardial</b> <b>infarction</b> (MI) an...|$|R
50|$|Bivalirudin {{clinical}} studies demonstrated consistent positive outcomes {{in patients with}} stable angina, unstable angina (UA), <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> (NSTEMI), and ST-segment elevation <b>myocardial</b> <b>infarction</b> (STEMI) undergoing PCI in 7 major randomized trials. Patients receiving bivalirudin had fewer adverse events compared to patients that received heparin.|$|R
40|$|Delirium tremens {{develops}} in {{a minority of}} patients undergoing acute alcohol withdrawal; however, that minority is vulnerable to significant morbidity and mortality. Historically, benzodiazepines are given intravenously to control withdrawal symptoms, although occasionally a more substantial medication is needed to prevent the devastating effects of delirium tremens, that is, propofol. We report a trauma patient who required propofol sedation for delirium tremens that was refractory to benzodiazepine treatment. Extubed prematurely, he suffered a <b>non-ST</b> <b>segment</b> <b>myocardial</b> <b>infarction</b> followed by an ST <b>segment</b> <b>myocardial</b> <b>infarction</b> requiring multiple interventions by cardiology. We hypothesize that his myocardial ischemia was secondary to an increased myocardial oxygen demand that occurred during his stress-induced catecholamine surge during {{the time he was}} undertreated for delirium tremens. This advocates for the use of propofol for refractory benzodiazepine treatment of delirium tremens and adds to the literature on the instability patients experience during withdrawal...|$|R
40|$|Background and objectives: In {{the general}} population, an early {{invasive}} strategy of routine coronary angiography {{is superior to}} a conservative strategy of selective angiography in patients who are admitted with unstable angina or <b>non–ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> (MI), but {{the effectiveness of this}} strategy in individuals with chronic kidney disease (CKD) is uncertain...|$|R
40|$|Aim: We {{assessed}} {{the management and}} outcomes of <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> (NSTEMI) patients randomly assigned to fractional flow reserve (FFR) -guided management or angiography-guided standard care. Methods and results: We conducted a prospective, multicentre, parallel group, 1 : 1 randomized, controlled trial in 350 NSTEMI patients with &# 8805; coronary stenosis &# 8805; 30...|$|R
40|$|Attribution License, which permits {{unrestricted}} use, distribution, {{and reproduction}} in any medium, provided the original work is properly cited. Delirium tremens develops in {{a minority of}} patients undergoing acute alcohol withdrawal; however, that minority is vulnerable to significant morbidity and mortality. Historically, benzodiazepines are given intravenously to control withdrawal symptoms, although occasionally a more substantial medication is needed to prevent the devastating effects of delirium tremens, that is, propofol. We report a trauma patient who required propofol sedation for delirium tremens that was refractory to benzodiazepine treatment. Extubed prematurely, he suffered a <b>non-ST</b> <b>segment</b> <b>myocardial</b> <b>infarction</b> followed by an ST <b>segment</b> <b>myocardial</b> <b>infarction</b> requiring multiple interventions by cardiology. We hypothesize that his myocardial ischemia was secondary to an increased myocardial oxygen demand that occurred during his stress-induced catecholamine surge during {{the time he was}} undertreated for delirium tremens. This advocates for the use of propofol for refractory benzodiazepine treatment of delirium tremens and adds to the literature on the instability patients experience during withdrawal. 1...|$|R
40|$|Palindromic {{rheumatism}} is a {{rare disease}} associated with systemic inflammation. Negative or constrictive coronary artery remodeling is typically not seen until the 7 th or 8 th decade of life. We report {{a case of a}} young female with palindromic rheumatism who suffered a <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> secondary to a flow-limiting lesion that demonstrated negative remodeling by intravascular ultrasound (IVUS) ...|$|R
40|$|AbstractWe {{assessed}} the CT attenuation {{density of the}} pulmonary tissue adjacent to the heart in patients with acute <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> (J. T. Kuhl, T. S. Kristensen, A. F. Thomsen et al., 2016) [1]. This data {{was related to the}} level of ground-glass opacification evaluated by a radiologist, and data on the interobserver variability of semi-automated assessment of pulmonary attenuation density was provided...|$|R
40|$|Background. The use of {{a single}} {{troponin}} measurement to exclude the diagnosis of <b>non-ST</b> <b>segment</b> <b>myocardial</b> <b>infarction</b> (NSTEMI) in patients that present with ischemic symptom duration ≥ 8 hours is sometimes used in the Emergency Department. Study Objective. To describe the characteristics of patients with initial nondiagnostic troponin values who develop a positive troponin while in the Emergency Department and to evaluate whether NSTEMI can be excluded using symptom duration ≥ 8 hours and initial troponin I. Methods. Retrospective chart review of patients evaluated for NSTEMI in the Emergency Department. Results. 4, 510 patients had at least two troponin I values obtained during the two-year study period. 115 (2. 5 %) of these patients had an initially nondiagnostic (0. 06 [*]ng/mL, but < 0. 6 [*]ng/mL). Only two of the remaining seven patients had a final primary diagnosis of NSTEMI. Conclusion. The {{use of a}} negative initial troponin I together with a symptom onset of ≥ 8 hours defines a population with a very low incidence of a hospital diagnosis of NSTEMI...|$|R
40|$|Case A 78 -year-old female with a past {{medical history}} of mild dementia, hypertension, diabetes, {{coronary}} artery disease status post automatic implantable cardioverter defibrillator (AICD) for congestive heart failure presented with suspected bacterial endocarditis and AICD lead infection from an outside hospital (OSH). The patient initially presented to the OSH with chest wall tenderness, fevers up to 101 ° F, chills, decreased appetite, weakness and weight loss. She {{was diagnosed with a}} <b>non-ST</b> <b>segment</b> <b>myocardial</b> <b>infarction</b> based on elevated troponin levels without electrocardiogram changes. At the OSH, blood acid fast bacillus (AFB) cultures were checked after routine blood cultures and fungal cultures were negative. Three separate blood cultures grew out Mycobacterium fortuitum over 3 different time intervals at the OSH. The patient was started on trimethoprim/ sulfamethoxazole 160 mg/ 800 mg orally three times a day and ciprofloxacin 500 mg orally twice a day. It was decided that definitive treatment for her persistent bacteremia and suspected endocarditis would require removal of the device and leads. The patient was transferred to Thomas Jefferson University Hospital (TJUH) for AICD lead removal and temporary pacemaker placement...|$|R
40|$|Essential thrombocythemia (ET) is a {{myeloproliferative}} neoplasm {{characterized by}} a clonal expansion of megakaryocytes. ET can result in both arterial and venous thrombosis. Involvement of the coronary arteries has been reported. Patients who harbor a CALR mutation are half as likely to suffer a thrombotic event as {{compared to patients with}} a JAK 2 mutation. We report a case of CALR-mutated ET whose initial disease manifestation was a <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction...</b>|$|R
40|$|License, which permits {{unrestricted}} use, distribution, {{and reproduction}} in any medium, provided the original work is properly cited. Palindromic rheumatism {{is a rare}} disease associated with systemic inflammation. Negative or constrictive coronary artery remodeling is typically not seen until the 7 th or 8 th decade of life. We report {{a case of a}} young female with palindromic rheumatism who suffered a <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> secondary to a flow-limiting lesion that demonstrated negative remodeling by intravascular ultrasound (IVUS). 1...|$|R
40|$|Bupivacaine {{is widely}} used as a local anesthetic. Central nervous system (CNS) and {{cardiovascular}} toxicity are well known side effects. However, {{there has been no}} report of bupivacaine-induced myocardial injury. We present a case of bupivacaine cardiac toxicity mimicking an acute <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction,</b> which was eventually diagnosed as bupivacaine-induced cardiac toxicity without CNS toxicity. As soon as a healthy young woman at a private clinic was given a spinal anesthesia of 6 mg bupivacaine for hemorrhoidectomy, she developed arrhythmia and hypotension. She was transferred to our emergency room. There was an accelerated idioventricular rhythm with ST segment depression on electrocardiogram, coarse breathing sounds with rales on whole lung field and a butterfly sign on the chest radiograph. 2 D transthoracic echocardiography (TTE) revealed reduced left ventricle systolic ejection fraction (approximately 27 %). There was regional wall motion abnormality of the left ventricle on 2 D TTE and the cardiac marker was increased. We diagnosed the patient as having acute <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> but her impaired cardiac function improved gradually. On the seventh day from admission, there was a complete spontaneous recovery of cardiac function, and coronary angiography revealed a normal coronary artery. Therefore, we firmly believe that bupivacaine directly injures the cardiac cell...|$|R
40|$|Copyright © 2011 Jeremy S. Lynn et al. This is an {{open access}} article {{distributed}} under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. The use of a single troponin measurement to exclude the diagnosis of <b>non-ST</b> <b>segment</b> <b>myocardial</b> <b>infarction</b> (NSTEMI) in patients that present with ischemic symptom duration ≥ 8 hours is sometimes used in the Emergency Department. Study Objective. To describe the characteristics of patients with initial nondiagnostic troponin values who develop a positive troponin while in the Emergency Department and to evaluate whether NSTEMI can be excluded using symptom duration ≥ 8 hours and initial troponin I. Methods. Retrospective chart review of patients evaluated for NSTEMI in the Emergency Department. Results. 4, 510 patients had at least two troponin I values obtained during the two-year study period. 115 (2. 5 %) of these patients had an initially nondiagnostic ( 0. 06 ng/mL, but < 0. 6 ng/mL). Only two of the remaining seven patients had a final primary diagnosis of NSTEMI. Conclusion. Theuseofanegative initial troponin I together with a symptom onset of ≥ 8 hours defines a population with a very low incidence of a hospital diagnosis of NSTEMI. 1...|$|R
40|$|OBJECTIVE: To {{document}} {{patterns of}} risk stratification, management practices, and outcomes among patients with acute coronary syndromes (ACS) presenting without high risk features. PATIENTS: The study {{was based on}} 11, 885 consecutive patients presenting with <b>non-ST</b> <b>segment</b> elevation ACS enrolled in GRACE (global registry of acute coronary events). Patients without dynamic ST segment changes, positive troponin (or other cardiac markers), or haemodynamic or arrhythmic instability were defined as being at lower risk. MAIN OUTCOME MEASURES: Management and outcomes were compared with high risk presentations. RESULTS: Of 11, 885 patients presenting with unstable angina or <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction,</b> 4252 (36...|$|R
40|$|Autoantibodies {{have been}} shown to play a {{critical}} role in predicting major adverse cardiovascular events in atherosclerotic patients. We aimed to assess the diagnostic accuracy of autoantibodies to apolipoprotein A- 1 (anti-apoA- 1 IgG) and to phosphorylcholine (anti-PC IgM) for <b>non-ST</b> <b>segment</b> elevation acute <b>myocardial</b> <b>infarction</b> (NSTEMI) and to explore their potential prognostic value...|$|R
40|$|One of {{the single}} {{anomalous}} origins of coronary artery that has rarely been reported is a congenital anomaly of coronary circulation that occurs in the left coronary artery originating from the right coronary sinus of valsalva. We report a 49 -year-old male patient with <b>non-ST</b> <b>segment</b> elevated <b>myocardial</b> <b>infarction</b> that was identified to have an anomalous origin of the left coronary artery from the right coronary artery (RCA) with thrombotic total occlusion of RCA by coronary angiography and cardiac computed tomography. The patient underwent successful percutaneous coronary intervention in total occlusion of the RCA and was discharged after uneventful recovery...|$|R
40|$|Copyright © 2015 Bassel Nazha et al. This is an {{open access}} article {{distributed}} under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by a clonal expansion of megakaryocytes. ET can result in both arterial and venous thrombosis. Involvement of the coronary arteries has been reported. Patients who harbor aCALR mutation are half as likely to suffer a thrombotic event as {{compared to patients with}} a JAK 2 mutation. We report a case of CALR-mutated ET whose initial disease manifestation was a <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction.</b> 1...|$|R
50|$|Individuals without ST segment {{elevation}} are {{presumed to}} be experiencing either unstable angina (UA) or <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> (NSTEMI). They receive {{many of the same}} initial therapies and are often stabilized with antiplatelet drugs and anticoagulated. If their condition remains (hemodynamically) stable, they can be offered either late coronary angiography with subsequent restoration of blood flow (revascularization), or non-invasive stress testing to determine if there is significant ischemia that would benefit from revascularization. If hemodynamic instability develops in individuals with NSTEMIs, they may undergo urgent coronary angiography and subsequent revascularization. The use of thrombolytic agents is contraindicated in this patient subset, however.|$|R
40|$|Coronary artery {{anomalies}} {{could be}} cause of confl icts for catheterization, especially, in the set-ting of acute coronary syndrome. We described {{a case of}} rare single coronary anomaly which the right coronary artery arisen from terminal part of left circumfl ex artery. Patient was presented with <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction.</b> Coronary angiography revealed subtotal steno-sis of left anterior descending artery at the mid portion. Left circumfl ex artery lying in usual route and branch out the posterior descending artery. The right coronary artery arisen from terminal circumfl ex artery. Left anterior descending artery lesion was stented without any complication. Key Words: Coronary vessel anomalies; acute coronary syndrome; catheterization. Received: 19. 03. 2012 ● Accepted: 25. 04. 201...|$|R
40|$|Due to the ageing {{population}} and raised life expectancy, elderly patients are increasingly referred for percutaneous coronary intervention (PCI) during acute coronary syndromes (ACS). Bleeding complications are not infrequent during ACS, occurring in 2 - 5 % {{of patients with}} prognostic and economic consequences. In particular, periprocedural bleeding and vascular complications are associated with worse clinical outcome, prolonged hospital stay and increased short- and long-term mortality, especially in elderly patients with acute coronary syndromes. We report {{the case of an}} 83 -year old female referred to our hospital because of <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> with high bleeding risk and unsuitable radial artery undergoing transulnar sheathless PCI during bivalirudin infusion. The clinical, technical, pharmacological and prognostic implications are discussed...|$|R
40|$|In most {{patients}} with heart failure due to left ventricular systolic dysfunction, {{the underlying cause}} is coronary heart disease. To reduce progression to heart failure in a patient with acute <b>myocardial</b> <b>infarction,</b> {{it is important to}} achieve the earliest possible reperfusion, whether by thrombolysis or primary percutaneous coronary intervention. Every patient with acute <b>myocardial</b> <b>infarction</b> should have an assessment of their left ventricular function, the potential for reversibility should be considered, and reversible ischaemia should be identified. Left ventricular dysfunction does not only occur with ST <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> but is also commonly associated with <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction.</b> Secondary prevention is crucial and this requires long term commitment by the patient and the health care system. Heart failure and left ventricular dysfunction are treatable but require a multidisciplinary, integrated network approach...|$|R
40|$|Objective: Percutaneous {{coronary}} {{intervention for}} anomalous right coronary artery (RCA) originating {{from the left}} coronary cusp is challenging because of our current inability to coaxially engage the guiding catheter. Methods: We report a case of an 88 -year-old woman with <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction,</b> with an anomalous RCA origin. Using either the Judkins-Left catheter or Amplatz-Left catheter was difficult because of RCA ostium tortuosity. Thus, we used steam to deform the Judkins-Left catheter, but back-up support was insufficient to deliver the stent. Results: We used GuideLiner®, a novel pediatric catheter with rapid exchange/monorail systems, to enhance back-up support. Conclusions: We were able to successfully stent with both the deformed Judkins-Left guiding catheter and GuideLiner® for an anomalous RCA origin...|$|R
40|$|Despite an {{increasing}} prevalence and {{burden of disease}} in the elderly, {{little is known about}} the management and outcomes of acute coronary syndromes in this group. We report the case of a 101 -year-old female patient with a <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction.</b> Coronary angiography showed a total occlusion of the proximal right coronary artery (RCA), and a significant stenosis in the proximal to mid left anterior descending artery (LAD). Despite a very poor initial clinical status, a percutaneous coronary intervention was successfully performed for the total occlusion in the RCA. The LAD lesion was treated with medical therapy only, on account of the age and general condition of the patient. She was discharged after recovering to a good health status, free of chest pain or dyspnea...|$|R
40|$|Copyright © 2013 Oguz Akkus et al. This is an {{open access}} article {{distributed}} under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Arterial stiffness parameters in patients who experienced MACE after acute MI have not been studied sufficiently. We investigated arterial stiffness parameters in patients with ST segment elevation (STEMI) and <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> (NSTEMI). Methods. Ninety-four patients with acute MI (45 STEMI and 49 NSTEMI) {{were included in the}} study. Arterial stiffness was assessed noninvasively by using TensioMed Arteriograph. Results. Arterial stiffness parameters were found to be higher in NSTEMI group but did not achieve statistical significance apart from pulse pressure...|$|R
40|$|Twenty-six years ago, as {{a medical}} resident, I {{admitted}} a 55 -year-old man with a large anterior-wall myo-cardial infarction. He had been previously “healthy,” although he had smoked one pack of cigarettes a day for 30 years. We treated him with lidocaine and nitroglycerine. On his eighth hospital day, he died suddenly of an autopsy-proven myocardial rupture. Five years ago, as an attending cardiologist, I admitted a 76 -year-old woman with a <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction.</b> She was overweight and had well-controlled hypertension, {{but she did not}} have diabetes. Given elevated levels of troponin T, we arranged coronary angiography, which showed a thrombus-laden lesion in her proximal circumfl ex artery, where my interventional colleague placed a stent. An echocardiogram showed left ventricula...|$|R
5000|$|Acute {{coronary}} syndrome (ACS) is a syndrome (set {{of signs}} and symptoms) due to decreased blood {{flow in the}} coronary arteries such {{that part of the}} heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, crushing, central and associated with nausea and sweating. Acute coronary syndrome is usually caused by one of three problems: ST elevation <b>myocardial</b> <b>infarction</b> (STEMI, 30%), non ST elevation <b>myocardial</b> <b>infarction</b> (NSTEMI, 25%), or unstable angina (38%).The death rate for ACS is one in three.These types are named according to the appearance of the electrocardiogram (ECG/EKG) as <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> and ST <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> [...] There can be some variation as to which forms of <b>myocardial</b> <b>infarction</b> (MI) are classified under acute coronary syndrome.|$|R
40|$|We {{read with}} {{interest}} the study by Kaya et al, 1 investigating the association between serum total bilirubin (sTB) level and the severity of coronary artery disease (CAD) assessed by SYNTAX score (SXscore) in patients with <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> (NSTEMI). The sTB levels were significantly greater in the high SXscore group (P. 001). Also, sTB level and SXscore were positively correlated (r. 495; P. 005). Although sTB {{was significantly associated with}} the severity of CAD, there was no significant association with long-term mortality. We have supportive comments on the article. Experimental and animal studies revealed that statins can induce hemeoxygenase 1 (HO- 1) activity and increase biliru-bin production. 2 - 4 However, the long-term effect of statin therapy on sTB levels in humans has not been investigate...|$|R
40|$|Antiplatelet {{drugs are}} used to prevent {{cardiovascular}} events and premature death in patients with multiple risk factors and in patients who have experienced Acute Coronary Syndrome (ACS) which includes unstable angina, <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> (NSTEMI), or ST <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> (STEMI). Other potential indications for antiplatelet drugs include history of transient ischemic attack or thromboembolic stroke, or symptomatic peripheral arterial disease. Aspirin has been considered the gold standard antiplatelet agent. Aspirin is effective in reducing the occurrence of major cardiovascular events including death, recurrent <b>myocardial</b> <b>infarction,</b> recurrent angina, or progression to severe angina and nonfatal stroke. Several practice guidelines have been published that provide recommendations regarding the role of aspirin. 1 2 3 4 5 6 Clopidogrel is used as an aspirin substitute for patients who are intolerant or contraindicated and {{as an adjunct to}} aspirin in patients who have receive...|$|R
40|$|A 71 {{year old}} patient {{presented}} with a <b>non-ST</b> <b>segment</b> elevation acute <b>myocardial</b> <b>infarction.</b> The echocardiogram showed several masses attached to the interatrial septum. Several days after admission the patient died. A postmortem examination found a large hepatocarcinoma with intravascular and intracardiac metastases and several <b>myocardial</b> <b>infarctions</b> of different ages. The infarctions had been caused by coronary paradoxical embolisms through a patent foramen ovale and contained neoplastic cells from the liver carcinoma, which had not been diagnosed. The {{cause of death was}} a massive pulmonary embolism...|$|R
40|$|The {{management}} {{of patients with}} acute coronary syndrome (ACS), including unstable angina, <b>non-ST</b> <b>segment</b> eleva-tion <b>myocardial</b> <b>infarction</b> (non-STEMI), and ST <b>segment</b> elevation <b>myocardial</b> <b>infarction</b> (STEMI), {{continues to be a}} chal-lenge for the health care industry. Despite numerous health care advances, ACS remains a major source of both morbidity and mortality. In 2005, there were approximately 772, 000 patients with ACS discharged from hospitals in the United States. 1 Further, <b>myocardial</b> <b>infarction</b> (MI) was the primary cause of death for nearly 157, 000 Americans in 2004 and a contributing cause of death for approximately 40, 000 additional persons. 1 In addition to primary prevention efforts, joint guidelines by the American College of Cardiology (ACC) and the American Heart Association (AHA) suggest secondary drug prevention measures to be used in patients with ACS. 2, 3 In conjunction with diet and lifestyle modifications, these guidelines suggest the use of statin, beta-blocker, and renin-angiotensin aldosterone system inhibito...|$|R
40|$|AbstractCoronary artery aneurysms in {{patients}} with Behçet's disease are rare and associated with fatal complications. Covered stents {{have been used in}} the management of coronary aneurysms but not {{in patients}} with Behçet's disease. We are reporting a rare case of Behçet's disease, admitted with <b>non-ST</b> <b>segment</b> elevation <b>myocardial</b> <b>infarction,</b> whose coronary angiogram revealed huge aneurysm involving proximal left anterior descending artery followed by severe stenosis. The stenosis was treated by drug-eluting stent and the aneurysm was successfully sealed with a covered stent. He remained asymptomatic at 3 -month follow-up and repeat angiogram showed patent stents. <Learning objective: There is no consensus upon the management of coronary artery aneurysm in a patient with Behçet's disease presenting with acute <b>myocardial</b> <b>infarction.</b> Sealing of aneurysm with covered stent and managing stenosis with drug-eluting stent can also be used for management in these patients with adequate use of immunosuppressant and anticoagulant. ...|$|R
